Latest Schedule 13G passive stakes

AQR Capital Management entities report a minor change in beneficial ownership of Avalanche Treasury Corporation's Class A common stock, now holding 7,040 shares representing 0.02% of the class.

Brandes Investment Partners, L.P. has reported a beneficial ownership of 5.3% in Embraer S.A. ADRs and Common Shares as of June 30, 2026.

Several investment entities, including Asia Equity Partners Limited and Baring Fintech entities, have jointly reported beneficial ownership of 7,106,927 American Depositary Shares (ADSs) in Joint Stock Co Kaspi.kz, representing 3.7% of the outstanding shares.

A group of entities and individuals associated with Stephens Inc. has reported beneficial ownership of 9.9% of Kura Sushi USA, Inc.'s Class A Common Stock as of June 30, 2026.

AQR Capital Management entities report a combined beneficial ownership of 5.85% in Elastic N.V. ordinary shares as of June 30, 2026.

AQR Capital Management entities report a 5.8% beneficial ownership of Ares Acquisition Corp III Class A ordinary shares.

Sands Capital entities report a combined 9.3% ownership in Inhibikase Therapeutics, Inc., holding over 13 million shares.

AQR Capital Management, LLC and AQR Capital Management Holdings, LLC have reported beneficial ownership of 6.34% of Molson Coors Beverage Co.'s Class B Common Stock.

AQR Capital Management entities report beneficial ownership of over 5% in Bitcoin Infrastructure Acquisition Corp Ltd Class A ordinary shares.

Investment group Invus discloses an increased beneficial ownership of enGene Therapeutics' common shares, now holding 9.3% of the outstanding stock.

Brandes Investment Partners, L.P. has reported beneficial ownership of 17,300,103 common shares of CAE Inc., representing 5.8% of the class.

AQR Capital Management, LLC and AQR Capital Management Holdings, LLC have reported beneficial ownership of 5.22% of DENTSPLY SIRONA Inc. common stock as of June 30, 2026.

AQR Capital Management reports a beneficial ownership of 5.98% in DraftKings Inc. Class A Common Stock as of June 30, 2026.

AQR Capital Management entities report beneficial ownership of 5.02% of Gesher Acquisition Corp. II Class A Ordinary Shares.

Sands Capital entities and Frank M. Sands jointly report beneficial ownership of 5.3% of Acrivon Therapeutics' common stock as of June 30, 2026.

AQR Capital Management entities report beneficial ownership of 5.99% of Keystone Acquisition Corp.'s Class A ordinary shares as of June 30, 2026.

AQR Capital Management, through its subsidiaries, has reported beneficial ownership of 6.26% of Velos Acquisition I Corp.'s Class A Ordinary Shares as of June 30, 2026.

Invus Public Equities, L.P. and affiliated entities have reported beneficial ownership of 9.4% of Nanobiotix S.A.'s ordinary shares, including shares issuable from warrants.

AQR Capital Management, LLC, AQR Capital Management Holdings, LLC, and AQR Arbitrage, LLC collectively report beneficial ownership of 1,219,750 Class A ordinary shares, representing 5.87% of the class, in NewHold Investment Corp IV.

AQR Capital Management, LLC and AQR Capital Management Holdings, LLC have reported a change in their beneficial ownership of Rubrik, Inc. Class A Common Stock.

AQR Capital Management, LLC and AQR Capital Management Holdings, LLC have reported an increased beneficial ownership of MarketAxess Holdings Inc. common stock, now holding 5.59% of the class.

A filing reveals that Invus Public Equities, L.P. and affiliated entities now collectively beneficially own 7.0% of Silence Therapeutics plc's ordinary shares.

Centiva Capital, LP and its general partner, Centiva Capital GP, LLC, have filed a Schedule 13G amendment indicating they beneficially own 0% of SUMA Acquisition Corporation's Class A ordinary shares.

AQR Capital Management, LLC and AQR Capital Management Holdings, LLC have filed an amendment to their Schedule 13G, reporting a beneficial ownership of 6.64% in Kyndryl Holdings, Inc.

Centiva Capital, LP and Centiva Capital GP, LLC have updated their beneficial ownership filing for ProCap Acquisition Corp, now holding 1.50% of the Class A ordinary shares.

Invus Public Equities, L.P. and affiliated entities have reported beneficial ownership of 8.0% of Scholar Rock Holding Corporation's common stock as of June 30, 2026.

AQR Capital Management, LLC and AQR Capital Management Holdings, LLC have filed a Schedule 13G, reporting beneficial ownership of 5.01% of Huntsman Corp's common stock.

Rosalind Advisors Inc. and its affiliated entities have reported beneficial ownership of 9.9% of Regentis Biomaterials Ltd.'s common shares, primarily through warrants and existing shares.

Several entities affiliated with Invus Group and Raymond Debbane have collectively acquired a 6.0% stake in Abivax S.A., signaling a notable investment in the biopharmaceutical company.

Several Artal Group entities have updated their beneficial ownership filings for CAVA Group, Inc., reporting a 5.6% stake as of June 30, 2026.